Director of Academic Affairs, Assessment, and Accreditation
Clinical Associate Professor
Wallace Marsh is the Director for Academic Affairs, Assessment, and Accreditation at the University of New England. Wallace received his BS in Pharmacy and MS and PhD in Pharmacy Administration from the University of Texas. He further earned his MBA and MSE from Nova Southeastern University. Past academic appointments include as the Assistant Dean for Assessment and Accreditation at the University of New England (2014-2016); and Interim Assistant Dean for Academic Affairs (2015-2016), Interim Assistant Dean for Assessment (2014-2015), and Director of the Division of Technology in Education (2006-2014) at the Shenandoah University School of Pharmacy.
Wallace teaches in the health care delivery, pharmacy management, and evidenced-based medicine courses. He has published over 25 peer-reviewed research articles and 2 book chapters.
Alston GL, Marsh WA, Castleberry AN, Kelley KA, Boyce EG. Pharmacists opinions of the value of specific applicant attributes in hiring decisions for entry-level pharmacists. Res Soc Admin Pharm 2019; 15:536-45. [https://doi.org/10.1016/j.sapharm.2018.07.004]
Patel I, GuyJ, Han Y, Marsh W, Pierce R, Johnson MS. Effects of Ebola Virus disease education on student health professionals. Curr Pharm Teach Learn 2018; 10:651-6 [https://doi.org/10.1016/j.cptl.2018.01.011].
Alston GL, Marsh WA, Castleberry AN, Kelley KA, Boyce EG. Pharmacists’ opinions of the value of CAPE outcomes in hiring decisionsAlston GL, Am J Pharm Educ 2017; 81(10): Article 6112
Rojas ME, Marsh W, Felici-Giovanini ME, Rodriquez-Benitez RJ, Zevallos JC. Impact of secondary prevention on mortality after a first ischemic stroke in Puerto Rico. PR Health Sci J 2017; 36(1): 11-16
Marsh WA, Brazeau GA. Rethinking our human resources. Am J Pharm Educ 2016; 80(2): Article 17.
Webber P, Marsh W, Jung L, Gardiner M, James J, McMullan P. Effectiveness of early identification and electronic interventions for teens with risk factors for development of heart disease and diabetes. JAANP 2016; 28(1):47-53.
Marsh WA, Monroe DM, Brin MF, Gallagher CJ. Systematic review and meta-analysis of the duration of clinical effect of onabotulinumtoxinA in cervical dystonia. BMC Neurology 2014; 14:91 (doi:10.1186/1471-2377-14-91).